[{"Assets_0_Q3_USD":"781524000.0","CIK":"1743881","CommonStockSharesIssued_0_Q3_shares":"153279652.0","CommonStockSharesOutstanding_0_Q3_shares":"147087891.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"-1.06","EarningsPerShareBasic_3_Q3_USD":"-2.88","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"1594164456.0","MinorityInterest_0_Q3_USD":"4556000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"-364039000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":"-155935000.0","NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":"-415362000.0","OfficialName":"BridgeBio Pharma Inc. Common Stock","ProfitLoss_1_Q3_USD":"-161016000.0","ProfitLoss_3_Q3_USD":"-434172000.0","RevenuesConverted_1_Q3_USD":"2344000.0","RevenuesConverted_3_Q3_USD":"56830000.0","SP500":null,"Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":"-738841000.0","StockholdersEquity_0_Q3_USD":"-743397000.0","Ticker":"BBIO","TreasuryStockSharesConverted_0_Q3_shares":"6191761.0","WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":"146662756.0","WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":"144044360.0","filed":"20211104","footnote":null,"form":"10-Q","fp":"Q3","fy":"2021.0","name":"BRIDGEBIO PHARMA, INC.","period":"20210930","qtrs":"0","uom":"USD"}]